Genzyme Corporation (GENZ) CEO Has $22M Conflict of Interest in Sanofi-Aventis (France) (SASY.PA) Buyout  
8/9/2010 8:40:19 AM

BNET -- To read the financial press, Sanofi-Aventisā€˜ (SNY) attempted acquisition of Genzyme (GENZ) is surrounded in mystery: The two sides are far apart on price and investors expect the haggling will take all summer. Will they agree a price or will Sanofi walk away, not willing to overpay?